235 related articles for article (PubMed ID: 22955957)
1. Efficacy and safety of higher doses of botulinum toxin type A NT 201 free from complexing proteins in the upper and lower limb spasticity after stroke.
Santamato A; Panza F; Ranieri M; Frisardi V; Micello MF; Filoni S; Fortunato F; Intiso D; Basciani M; Logroscino G; Fiore P
J Neural Transm (Vienna); 2013 Mar; 120(3):469-76. PubMed ID: 22955957
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety of repeated high doses of incobotulinumtoxinA injections for the treatment of upper and lower limb spasticity after stroke.
Santamato A; Panza F; Intiso D; Baricich A; Picelli A; Smania N; Fortunato F; Seripa D; Fiore P; Ranieri M
J Neurol Sci; 2017 Jul; 378():182-186. PubMed ID: 28566161
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
[TBL] [Abstract][Full Text] [Related]
5. Employment of higher doses of botulinum toxin type A to reduce spasticity after stroke.
Santamato A; Micello MF; Ranieri M; Valeno G; Albano A; Baricich A; Cisari C; Intiso D; Pilotto A; Logroscino G; Panza F
J Neurol Sci; 2015 Mar; 350(1-2):1-6. PubMed ID: 25684341
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
Buyukavci R; Akturk S; Ersoy Y
Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Extracorporeal Shock Wave Therapy after Botulinum Toxin Injection for Post-Stroke Upper Extremity Spasticity: A Randomized Controlled Study.
Lee J; Yang SN
Toxins (Basel); 2024 Apr; 16(4):. PubMed ID: 38668622
[TBL] [Abstract][Full Text] [Related]
8. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin type A in post-stroke upper limb spasticity.
Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
Curr Med Res Opin; 2010 Aug; 26(8):1983-92. PubMed ID: 20569068
[TBL] [Abstract][Full Text] [Related]
10. Treatment of upper limb spasticity after stroke: one-year safety and efficacy of botulinum toxin type A NT201.
Fiore P; Santamato A; Ranieri M; Bellomo RG; Saggini R; Panza F; Megna G; Cristella G; Megna M
Int J Immunopathol Pharmacol; 2012; 25(1 Suppl):57S-62S. PubMed ID: 22652163
[TBL] [Abstract][Full Text] [Related]
11. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
Baguley IJ; Nott MT; Turner-Stokes L; De Graaff S; Katrak P; McCrory P; de Abadal M; Hughes A
J Rehabil Med; 2011 Nov; 43(11):1032-7. PubMed ID: 22031350
[TBL] [Abstract][Full Text] [Related]
12. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
Elovic EP; Brashear A; Kaelin D; Liu J; Millis SR; Barron R; Turkel C
Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase.
Abo M; Shigematsu T; Hara H; Matsuda Y; Nimura A; Yamashita Y; Takahashi K
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32085529
[TBL] [Abstract][Full Text] [Related]
14. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review.
Olvey EL; Armstrong EP; Grizzle AJ
Clin Ther; 2010 Dec; 32(14):2282-303. PubMed ID: 21353101
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE).
Masakado Y; Abo M; Kondo K; Saeki S; Saitoh E; Dekundy A; Hanschmann A; Kaji R;
J Neurol; 2020 Jul; 267(7):2029-2041. PubMed ID: 32219557
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.
Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
J Neurol; 2010 Aug; 257(8):1330-7. PubMed ID: 20358216
[TBL] [Abstract][Full Text] [Related]
17. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.
Bakheit AM; Thilmann AF; Ward AB; Poewe W; Wissel J; Muller J; Benecke R; Collin C; Muller F; Ward CD; Neumann C
Stroke; 2000 Oct; 31(10):2402-6. PubMed ID: 11022071
[TBL] [Abstract][Full Text] [Related]
19. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: a meta-analysis.
Cardoso E; Rodrigues B; Lucena R; Oliveira IR; Pedreira G; Melo A
Arq Neuropsiquiatr; 2005 Mar; 63(1):30-3. PubMed ID: 15830061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
